Erin Sinram, PA
Physician Assistant · Fairbank, IANPI 1093093361
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 265 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 32.3% of the total. Among physician assistant clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 265 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$622
- Novo Nordisk$464
- Boehringer Ingelheim$333
- Pfizer$242
- Mylan Specialty L.p.$239
- plus $892 from 14 others
What the payments were for
- Food & beverage$4,122100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 93 | $1,331 |
| Lilly USA, LLC | 36 | $622 |
| Novo Nordisk | 30 | $464 |
| Boehringer Ingelheim | 20 | $333 |
| Pfizer | 17 | $242 |
| Mylan Specialty L.p. | 17 | $239 |
| Phathom Pharmaceuticals, Inc. | 9 | $202 |
| Johnson & Johnson | 8 | $127 |
| Amgen | 6 | $95 |
| Exact Sciences | 5 | $90 |
| Idorsia Pharmaceuticals US Inc | 5 | $74 |
| AstraZeneca | 4 | $61 |
| Bayer | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Viatris Specialty LLC | 2 | $38 |
| GSK | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Vertex | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Novartis | 1 | $13 |
How this compares
$4,122 in reported general payments places this provider in the 95th percentile of 1,140 physician assistant providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 55 | $44,083 |
| OzempicSemaglutide | 40 | $34,017 |
| JardianceEmpagliflozin | 38 | $30,960 |
| XareltoRivaroxaban | 20 | $21,248 |
| Dexlansoprazole DrDexlansoprazole | 18 | $10,464 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $7,868 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,353 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $3,255 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,054 |
| Gabapentin | 46 | $1,804 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $1,477 |
| Potassium Chloride | 62 | $1,426 |
| Levothyroxine Sodium | 168 | $1,365 |
| Atorvastatin Calcium | 192 | $1,351 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 65 | $1,259 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $242 | $44,08355 claims |
| Novo NordiskOzempic | $464 | $34,01740 claims |
| Boehringer IngelheimJardiance | $333 | $30,96038 claims |
| Johnson & JohnsonXarelto | $127 | $21,24820 claims |
| GSKBreo Ellipta | $34 | $4,35311 claims |
| AstraZenecaSymbicort | $61 | $3,05413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,140 physician assistant providers in Iowa.
Other physician assistant in Fairbank
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
- Michon LeddyClive$73K
- Kyle HawkinsIowa City$42K
- Andrew MetzgerIowa City$37K
- Myrl HolidaIowa City$37K
- Kelly MerchieDavenport$15K
- Kathleen DuffyClive$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.